metoclopramide has been researched along with Adenocarcinoma of Lung in 1 studies
Metoclopramide: A dopamine D2 antagonist that is used as an antiemetic.
metoclopramide : A member of the class of benzamides resulting from the formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with the primary amino group of N,N-diethylethane-1,2-diamine.
Adenocarcinoma of Lung: A carcinoma originating in the lung and the most common lung cancer type in never-smokers. Malignant cells exhibit distinct features such as glandular epithelial, or tubular morphology. Mutations in KRAS, EGFR, BRAF, and ERBB2 genes are associated with this cancer.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Crizotinib is an orally active multi-target tyrosine kinase inhibitor which is the standard of care in patients with anaplastic lymphoma kinase translocated non-small-cell lung cancer." | 5.42 | When crizotinib-induced bradycardia becomes symptomatic: role of concomitant drugs. ( Aieta, M; Gallucci, G; Lombardi, L; Tartarone, A, 2015) |
| "Crizotinib is an orally active multi-target tyrosine kinase inhibitor which is the standard of care in patients with anaplastic lymphoma kinase translocated non-small-cell lung cancer." | 1.42 | When crizotinib-induced bradycardia becomes symptomatic: role of concomitant drugs. ( Aieta, M; Gallucci, G; Lombardi, L; Tartarone, A, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gallucci, G | 1 |
| Tartarone, A | 1 |
| Lombardi, L | 1 |
| Aieta, M | 1 |
1 other study available for metoclopramide and Adenocarcinoma of Lung
| Article | Year |
|---|---|
When crizotinib-induced bradycardia becomes symptomatic: role of concomitant drugs.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Combined Chemotherapy Protocols; Bradycardia; | 2015 |